Dr. Ryan Mathis is the Vice President of Commercial Strategy at PolarityTE, focusing on bringing regenerative medicine into clinical practice, particularly for treating diabetic foot ulcers and other forms of complex wounds. Ryan says, “So, we’re trying to solve this problem by developing SkinTE, which is revolutionizing the science for these hard-to-close wounds. The product itself […]

An unusual factor XI inhibitor Novartis had given up on might have a shot at approval after all. Abelacimab, now in development by the private company Anthos Therapeutics, has shown the utility of this mechanism by scoring in a mid-stage trial in preventing venous thromboembolism. The highest two of three doses of the project beat […]

When a patient develops cancer, two different cancer-derived materials can be found in their blood: intact circulating tumour cells (CTCs) and cell-free circulating tumour DNA (cfDNA), which is released into the bloodstream as tumours grow. Clinicians can use blood drawn from a patient’s arm to search for CTCs and cfDNA that may be circulating in […]